Downloads: 1
| # | NCT02750826 | 3136 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"HER2/Neu Negative" | name:"HER2/Neu Negative" | synonyms:["HER-2 Negative" | ERBB2 Negative | HER2 Negative] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C68749" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Stratification Factor | Eligibility Criterion - Inclusion" | long_name:"Progesterone Receptor Positive" | name:"Progesterone Receptor Positive" | synonyms:[" PGR Positive" | PR Positive] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15496" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Stratification Factor | Eligibility Criterion - Inclusion" | long_name:"Estrogen Receptor Negative" | name:"Estrogen Receptor Negative" | synonyms:["ESR Negative" | ER Negative | Negative Estrogen Receptor] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15493" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Stratification Factor | Eligibility Criterion - Inclusion" | long_name:"Progesterone Receptor Negative" | name:"Progesterone Receptor Negative" | synonyms:["PGR Negative" | PR Negative] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15497" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Stratification Factor | Eligibility Criterion - Inclusion" | long_name:"Estrogen Receptor Positive" | name:"Estrogen Receptor Positive" | synonyms:["ER Positive" | ESR Positive | Positive Estrogen Receptor] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15492" | eligibility_criterion:"inclusion"}]" | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01674140 | 1900 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"HER2/Neu Negative" | name:"HER2/Neu Negative" | synonyms:["HER-2 Negative" | ERBB2 Negative | HER2 Negative] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C68749" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Progesterone Receptor Positive" | name:"Progesterone Receptor Positive" | synonyms:[" PGR Positive" | PR Positive] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15496" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Estrogen Receptor Positive" | name:"Estrogen Receptor Positive" | synonyms:["ER Positive" | ESR Positive | Positive Estrogen Receptor] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15492" | eligibility_criterion:"inclusion"}]" | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 | NCT02927249 | 2936 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Triple-Negative Breast Cancer Finding" | name:"Triple-Negative Breast Cancer Finding" | synonyms:["Triple-Negative Breast Cancer Result" | Triple Negative Breast Cancer Result | ER/PR/HER2 Negative | ER-negative PR-negative HER2/neu-negative | ESR1/PGR/ERBB2 Negative Finding | ER-Negative PR-Negative ERBB2-Negative | Triple Negative Breast Cancer Finding | ER-PR-HER2/neu-] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C71428" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"HER2/Neu Negative" | name:"HER2/Neu Negative" | synonyms:["HER-2 Negative" | ERBB2 Negative | HER2 Negative] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C68749" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Progesterone Receptor Negative" | name:"Progesterone Receptor Negative" | synonyms:["PGR Negative" | PR Negative] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15497" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Estrogen Receptor Negative" | name:"Estrogen Receptor Negative" | synonyms:["ESR Negative" | ER Negative | Negative Estrogen Receptor] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15493" | eligibility_criterion:"inclusion"}]" | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 | NCT02465060 | 6452 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 | NCT02488967 | 990 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"HER2/Neu Negative" | name:"HER2/Neu Negative" | synonyms:["HER-2 Negative" | ERBB2 Negative | HER2 Negative] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C68749" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Estrogen Receptor Negative" | name:"Estrogen Receptor Negative" | synonyms:["ESR Negative" | ER Negative | Negative Estrogen Receptor] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15493" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Progesterone Receptor Negative" | name:"Progesterone Receptor Negative" | synonyms:["PGR Negative" | PR Negative] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15497" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Triple-Negative Breast Cancer Finding" | name:"Triple-Negative Breast Cancer Finding" | synonyms:["Triple-Negative Breast Cancer Result" | Triple Negative Breast Cancer Result | ER/PR/HER2 Negative | ER-negative PR-negative HER2/neu-negative | ESR1/PGR/ERBB2 Negative Finding | ER-Negative PR-Negative ERBB2-Negative | Triple Negative Breast Cancer Finding | ER-PR-HER2/neu-] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C71428" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Progesterone Receptor Positive" | name:"Progesterone Receptor Positive" | synonyms:[" PGR Positive" | PR Positive] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15496" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Estrogen Receptor Positive" | name:"Estrogen Receptor Positive" | synonyms:["ER Positive" | ESR Positive | Positive Estrogen Receptor] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15492" | eligibility_criterion:"inclusion"}]" | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 | NCT03373760 | 132 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 | NCT01901094 | 2918 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 | NCT02193282 | 450 | [{assay_purpose":"Stratification Factor | Eligibility Criterion - Inclusion" | long_name:"EGFR Gene Exon Deletion Mutation Nineteen" | name:"EGFR Exon 19 Deletion" | synonyms:["mENA Exon 19 Deletion Mutation" | HER1 Exon 19 Deletion Mutation | mENA Exon 19 Deletion | HER1 Exon 19 Deletion | ERBB1 Exon 19 Deletion Mutation | ERBB Exon 19 Deletion | ERBB Exon 19 Deletion Mutation | Epidermal Growth Factor Receptor Exon 19 Deletion Mutation | PIG61 Exon 19 Deletion Mutation | PIG61 Exon 19 Deletion | ERBB1 Exon 19 Deletion | EGFR Exon 19 Deletion Mutation | Epidermal Growth Factor Receptor Exon 19 Deletion] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C17757:C13231:C19296:C105801" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"EGFR exon 21 L858R mutation" | name:"EGFR exon 21 L858R mutation" | synonyms:["HER1 c.2572_2573CT>AG" | ERBB1 c.2573_2574TG>GT | EGFR NM_005228.3:c.2573T>G | Epidermal Growth Factor Receptor L858R | ERBB1 c.2572_2573CT>AG | NM_005228.3:c.2572_2573CT>AG | EGFR c.2572_2573delCTinsAG | Proto-Oncogene c-ErbB-1 L858R | ERBB1 c.2573T>G | EGFR NM_005228.3:c.2572_2573delCTinsAG | EGFR NP_005219.2:p.Leu858Arg | ERBB c.2573T>G | ERBB c.2573_2574TG>GT | EGFR NP_005219.2:p.L858R | EGFR c.2573_2574TG>GT | Epidermal Growth Factor Receptor Gene c.2573T>G | EGFR p.Leu858Arg | NM_005228.3:c.2573T>G | EGFR p.L858R | HER1 c.2573_2574TG>GT | EGFR c.2573_2574delTGinsGT | Receptor Tyrosine-Protein Kinase erbB-1 L858R | Epidermal Growth Factor Receptor Gene c.2572_2573CT>AG | EGFR c.2572_2573CT>AG | EGFR NM_005228.3:c.2573_2574delTGinsGT | NM_005228.3:c.2573_2574TG>GT | Epidermal Growth Factor Receptor Gene c.2573_2574TG>GT | ERBB c.2572_2573CT>AG | C98515:C98357 | NM_005228.3:c.2573_2574delTGinsGT | EGFR L858R | NM_005228.3:c.2572_2573delCTinsAG | HER1 c.2573T>G | EGFR Leu858Arg | NP_005219.2:p.Leu858Arg | EGFR c.2573T>G] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C98516:C98517:C98518:C98515" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Exclusion" | long_name:"T790M EGFR Gene Mutation" | name:"EGFR T790M" | synonyms:["T790M EGFR Gene Mutation"] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C98504:C98503" | eligibility_criterion:"exclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"ALK Gene Rearrangement" | name:"ALK Gene Rearrangement" | synonyms:["Anaplastic Lymphoma Kinase Gene Rearrangement"] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C129574" | eligibility_criterion:"inclusion"}]" | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 | NCT02834013 | 707 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9 | NCT01515787 | 1120 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10 | NCT02445391 | 562 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"HER2/Neu Negative" | name:"HER2/Neu Negative" | synonyms:["HER-2 Negative" | ERBB2 Negative | HER2 Negative] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C68749" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Estrogen Receptor Negative" | name:"Estrogen Receptor Negative" | synonyms:["ESR Negative" | ER Negative | Negative Estrogen Receptor] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15493" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Triple-Negative Breast Cancer Finding" | name:"Triple-Negative Breast Cancer Finding" | synonyms:["Triple-Negative Breast Cancer Result" | Triple Negative Breast Cancer Result | ER/PR/HER2 Negative | ER-negative PR-negative HER2/neu-negative | ESR1/PGR/ERBB2 Negative Finding | ER-Negative PR-Negative ERBB2-Negative | Triple Negative Breast Cancer Finding | ER-PR-HER2/neu-] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C71428" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Response Assessment | Eligibility Criterion - Inclusion" | long_name:"PAM50 Gene Expression Signature" | name:"PAM50 Gene Expression Signature" | synonyms:["Prediction Analysis of Microarray 50" | PAM50] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C120494" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Progesterone Receptor Negative" | name:"Progesterone Receptor Negative" | synonyms:["PGR Negative" | PR Negative] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15497" | eligibility_criterion:"inclusion"}]" | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 11 | NCT01863550 | 1080 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 12 | NCT02595905 | 333 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Triple-Negative Breast Cancer Finding" | name:"Triple-Negative Breast Cancer Finding" | synonyms:["Triple-Negative Breast Cancer Result" | Triple Negative Breast Cancer Result | ER/PR/HER2 Negative | ER-negative PR-negative HER2/neu-negative | ESR1/PGR/ERBB2 Negative Finding | ER-Negative PR-Negative ERBB2-Negative | Triple Negative Breast Cancer Finding | ER-PR-HER2/neu-] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C71428" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Deleterious BRCA2 Gene Mutation" | name:"Deleterious BRCA2 Gene Mutation" | synonyms:["Deleterious Breast Cancer Type 2 Susceptibility Gene Mutation" | Deleterious BROVCA2 Gene Mutation] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C128815" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"HER2/Neu Negative" | name:"HER2/Neu Negative" | synonyms:["HER-2 Negative" | ERBB2 Negative | HER2 Negative] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C68749" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Progesterone Receptor Negative" | name:"Progesterone Receptor Negative" | synonyms:["PGR Negative" | PR Negative] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15497" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Estrogen Receptor Negative" | name:"Estrogen Receptor Negative" | synonyms:["ESR Negative" | ER Negative | Negative Estrogen Receptor] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15493" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Deleterious BRCA1 Gene Mutation" | name:"Deleterious BRCA1 Gene Mutation" | synonyms:["Deleterious BROVCA1 Gene Mutation" | Deleterious Breast Cancer Type 1 Susceptibility Gene Mutation] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C128814" | eligibility_criterion:"inclusion"}]" | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 13 | NCT02595944 | 714 | [{assay_purpose":"Eligibility Criterion - Exclusion" | long_name:"EGFR Gene Exon Deletion Mutation Nineteen" | name:"EGFR Exon 19 Deletion" | synonyms:["mENA Exon 19 Deletion Mutation" | HER1 Exon 19 Deletion Mutation | mENA Exon 19 Deletion | HER1 Exon 19 Deletion | ERBB1 Exon 19 Deletion Mutation | ERBB Exon 19 Deletion | ERBB Exon 19 Deletion Mutation | Epidermal Growth Factor Receptor Exon 19 Deletion Mutation | PIG61 Exon 19 Deletion Mutation | PIG61 Exon 19 Deletion | ERBB1 Exon 19 Deletion | EGFR Exon 19 Deletion Mutation | Epidermal Growth Factor Receptor Exon 19 Deletion] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C17757:C13231:C19296:C105801" | eligibility_criterion:"exclusion"} | {"assay_purpose":"Eligibility Criterion - Exclusion" | long_name:"EGFR exon 21 L858R mutation" | name:"EGFR exon 21 L858R mutation" | synonyms:["HER1 c.2572_2573CT>AG" | ERBB1 c.2573_2574TG>GT | EGFR NM_005228.3:c.2573T>G | Epidermal Growth Factor Receptor L858R | ERBB1 c.2572_2573CT>AG | NM_005228.3:c.2572_2573CT>AG | EGFR c.2572_2573delCTinsAG | Proto-Oncogene c-ErbB-1 L858R | ERBB1 c.2573T>G | EGFR NM_005228.3:c.2572_2573delCTinsAG | EGFR NP_005219.2:p.Leu858Arg | ERBB c.2573T>G | ERBB c.2573_2574TG>GT | EGFR NP_005219.2:p.L858R | EGFR c.2573_2574TG>GT | Epidermal Growth Factor Receptor Gene c.2573T>G | EGFR p.Leu858Arg | NM_005228.3:c.2573T>G | EGFR p.L858R | HER1 c.2573_2574TG>GT | EGFR c.2573_2574delTGinsGT | Receptor Tyrosine-Protein Kinase erbB-1 L858R | Epidermal Growth Factor Receptor Gene c.2572_2573CT>AG | EGFR c.2572_2573CT>AG | EGFR NM_005228.3:c.2573_2574delTGinsGT | NM_005228.3:c.2573_2574TG>GT | Epidermal Growth Factor Receptor Gene c.2573_2574TG>GT | ERBB c.2572_2573CT>AG | C98515:C98357 | NM_005228.3:c.2573_2574delTGinsGT | EGFR L858R | NM_005228.3:c.2572_2573delCTinsAG | HER1 c.2573T>G | EGFR Leu858Arg | NP_005219.2:p.Leu858Arg | EGFR c.2573T>G] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C98516:C98517:C98518:C98515" | eligibility_criterion:"exclusion"} | {"assay_purpose":"Eligibility Criterion - Exclusion" | long_name:"ALK Gene Rearrangement" | name:"ALK Gene Rearrangement" | synonyms:["Anaplastic Lymphoma Kinase Gene Rearrangement"] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C129574" | eligibility_criterion:"exclusion"}]" | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 14 | NCT01953588 | 2060 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"HER2/Neu Negative" | name:"HER2/Neu Negative" | synonyms:["HER-2 Negative" | ERBB2 Negative | HER2 Negative] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C68749" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Response Assessment | Eligibility Criterion - Inclusion" | long_name:"Estrogen Receptor Positive" | name:"Estrogen Receptor Positive" | synonyms:["ER Positive" | ESR Positive | Positive Estrogen Receptor] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15492" | eligibility_criterion:"inclusion"}]" | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 15 | NCT02154490 | 10000 | [{assay_purpose":"Treatment Assignment | Eligibility Criterion - Inclusion" | long_name:"FGFR2 Gene Amplification" | name:"FGFR2 Amplification" | synonyms:["FGFR-2 Gene Amplification" | K-SAM Gene Amplification | CD332 Gene Mutation | BEK Gene Amplification | ECT1 Gene Amplification | FGFR2 Gene Activation | Fibroblast Growth Factor Receptor 2 Gene Amplification | FGFR2 Gene Amplification | Fibroblast Growth Factor Receptor 2 Gene Activation | KGFR Gene Amplification] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C36651" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Treatment Assignment | Eligibility Criterion - Inclusion" | long_name:"FGFR2 Gene Mutation" | name:"FGFR2 Gene Mutation" | synonyms:["CD332 Gene Mutation" | BEK Gene Mutation | KGFR Gene Mutation | ECT1 Gene Mutation | FGFR-2 Gene Mutation | K-SAM Gene Mutation | Fibroblast Growth Factor Receptor 2 Gene Mutation] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C107579" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Treatment Assignment | Eligibility Criterion - Inclusion" | long_name:"CCND3 Gene Amplification" | name:"CCND3 Gene Amplification" | synonyms:["Cyclin D3 Gene Amplification"] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C131784" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Treatment Assignment | Eligibility Criterion - Inclusion" | long_name:"FGFR1 Gene Amplification" | name:"FGFR1 Amplification" | synonyms:["Fibroblast Growth Factor Receptor 1 Gene Amplification" | OGD Gene Amplification | CD331 Gene Amplification | FLT-2 Gene Amplification | FGFR-1 Gene Amplification | Fibroblast Growth Factor Receptor 1 Gene Activation | N-SAM Gene Amplification | FLG Gene Amplification | FGFR1 Gene Activation | FMS-Like Tyrosine Kinase 2 Gene Amplification | KAL2 Gene Amplification | FGFR1 Gene Amplification | FGFBR Gene Amplification | CEK Gene Amplification | BFGFR Gene Amplification | FLT2 Gene Amplification] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C36650" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Treatment Assignment | Eligibility Criterion - Inclusion" | long_name:"CCND2 Gene Amplification" | name:"CCND2 Gene Amplification" | synonyms:["Cyclin D2 Gene Amplification"] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C131785" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Exclusion" | long_name:"EGFR Gene Mutation" | name:"EGFR Gene Mutation" | synonyms:["ERBB Gene Mutation" | HER1 Gene Mutation | Epidermal Growth Factor Receptor Gene Mutation | ERBB1 Gene Mutation] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C98357" | eligibility_criterion:"exclusion"} | {"assay_purpose":"Treatment Assignment | Response Assessment | Eligibility Criterion - Inclusion" | long_name:"CCND1 Gene Amplification" | name:"CCND1 Gene Amplification" | synonyms:["Cyclin D1 Gene Activation" | BCL1 Gene Amplification | PRAD1 Gene Amplification | BCL-1 Gene Amplification | Cyclin D1 Gene Amplification | CCND1 Gene Activation] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C36652" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Treatment Assignment | Eligibility Criterion - Inclusion" | long_name:"FGFR3 Gene Mutation" | name:"FGFR3 Gene Mutation" | synonyms:["Fibroblast Growth Factor Receptor 3 Gene Mutation" | FGFR-3 Gene Mutation | JKT4 Gene Mutation | CD333 Gene Mutation] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C39877" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Exclusion" | long_name:"ALK Gene Mutation" | name:"ALK Gene Mutation" | synonyms:["Anaplastic Lymphoma Kinase Receptor Gene Mutation" | Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Mutation | CD246 Gene Mutation] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C81945" | eligibility_criterion:"exclusion"} | {"assay_purpose":"Treatment Assignment | Eligibility Criterion - Inclusion" | long_name:"CDK4 Gene Amplification" | name:"CDK4 Gene Amplification" | synonyms:["Cell Division Kinase 4 Gene Amplification" | Cyclin Dependent Kinase 4 Gene Amplification] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C131786" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Treatment Assignment | Eligibility Criterion - Inclusion" | long_name:"FGFR1 Gene Mutation" | name:"FGFR1 Gene Mutation" | synonyms:["FGFR-1 Gene Mutation" | BFGFR Gene Mutation | FLG Gene Mutation | CEK Gene Mutation | CD331 Gene Mutation | N-SAM Gene Mutation | FMS-Like Tyrosine Kinase 2 Gene Mutation | FGFBR Gene Mutation | Fibroblast Growth Factor Receptor 1 Gene Mutation | KAL2 Gene Mutation | FLT2 Gene Mutation | FLT-2 Gene Mutation | OGD Gene Mutation] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C129632" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Treatment Assignment | Stratification Factor | Eligibility Criterion - Inclusion" | long_name:"PIK3CA Gene Mutation" | name:"PIK3CA Gene Mutation" | synonyms:["PI3K Gene Mutation" | Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha Gene Mutation] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C96271" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Treatment Assignment | Eligibility Criterion - Inclusion" | long_name:"Homologous Recombination Repair Deficiency Positive" | name:"Homologous Recombination Repair Deficiency Positive" | synonyms:[] | hugo_biomarker_code:null | nci_thesaurus_concept_id:null | eligibility_criterion:"inclusion"} | {"assay_purpose":"Treatment Assignment | Eligibility Criterion - Inclusion" | long_name:"MET Positive" | name:"MET Positive" | synonyms:["MET Proto-Oncogene | Receptor Tyrosine Kinase Positive" | c-met Positive | Hepatocyte Growth Factor Receptor Positive | HGFR Positive | Met Proto-Oncogene Positive] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C131068" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Treatment Assignment | Eligibility Criterion - Inclusion" | long_name:"FGFR3 Gene Amplification" | name:"FGFR3 Amplification" | synonyms:["FGFR-3 Gene Amplification" | JKT4 Gene Amplification | FGFR3 Gene Amplification | CD333 Gene Amplification | Fibroblast Growth Factor Receptor 3 Gene Amplification] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C129621" | eligibility_criterion:"inclusion"}]" |
| 16 | NCT00632853 | 729 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 17 | NCT03365882 | 130 | [{assay_purpose":"Eligibility Criterion - Exclusion" | long_name:"NRAS NP_002515.1:p.G13X" | name:"NRAS G13 Mutation" | synonyms:["NRAS G13X" | NRAS NP_002515.1:p.G13X | Transforming Protein N-Ras G13X | NRAS NP_002515.1 :p.Gly12Xxx | GTPase NRas G13X | NRAS p.G13X | NRAS Gly12Xxx | NP_002515.1 :p.Gly12Xxx | NRAS p.Gly12Xxx] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C107484" | eligibility_criterion:"exclusion"} | {"assay_purpose":"Eligibility Criterion - Exclusion" | long_name:"NRAS Exon 4 Gene Mutation" | name:"NRAS Exon 4 Gene Mutation" | synonyms:[] | hugo_biomarker_code:null | nci_thesaurus_concept_id:null | eligibility_criterion:"exclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"ERBB2 Gene Amplification" | name:"HER2 Amplification" | synonyms:["ERBB2 Gene Amplification" | HER2/Neu Amplification | c-erbB2 Gene Amplification | HER-2 Gene Amplification | ERBB2 Amplification | c-erbB2 Gene Activation | HER2 Gene Amplification] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C36638" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Exclusion" | long_name:"KRAS NP_004976.2:p.G13X" | name:"KRAS G13 Mutation" | synonyms:["KRAS G13X" | c-K-ras G13X | KRAS NP_004976.2:p.G13X | KRAS NP_004976.2:p.Gly13Xxx | KRAS p.Gly13Xxx | NP_004976.2:p.Gly13Xxx | KRAS p.G13X | KRAS Codon 13 Mutation | Ki-Ras G13X | KRAS Gly13Xxx | GTPase KRas G13X | K-Ras 2 G13X] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C117177" | eligibility_criterion:"exclusion"} | {"assay_purpose":"Eligibility Criterion - Exclusion" | long_name:"BRAF NP_004324.2:p.V600E" | name:"BRAF V600E Mutation" | synonyms:[] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C98342" | eligibility_criterion:"exclusion"} | {"assay_purpose":"Eligibility Criterion - Exclusion" | long_name:"KRAS NP_004976.2:p.G12X" | name:"KRAS G12 Mutation" | synonyms:["KRAS Codon 12 Mutation" | NP_004976.2:p.Gly12Xxx | c-K-ras G12X | KRAS p.Gly12Xxx | KRAS G12X | K-Ras 2 G12X | KRAS p.G12X | KRAS NP_004976.2:p.G12X | KRAS NP_004976.2:p.Gly12Xxx | KRAS Gly12Xxx | Ki-Ras G12X | GTPase KRas G12X] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C117180" | eligibility_criterion:"exclusion"} | {"assay_purpose":"Eligibility Criterion - Exclusion" | long_name:"KRAS Exon 4 Gene Mutation" | name:"KRAS Exon 4 Gene Mutation" | synonyms:[] | hugo_biomarker_code:null | nci_thesaurus_concept_id:null | eligibility_criterion:"exclusion"} | {"assay_purpose":"Eligibility Criterion - Exclusion" | long_name:"NRAS NP_002515.1:p.G12X" | name:"NRAS G12 Mutation" | synonyms:["GTPase NRas G12X" | NRAS p.Gly12Xxx | NRAS Gly12Xxx | NRAS NP_002515.1 :p.Gly12Xxx | NP_002515.1 :p.Gly12Xxx | NRAS NP_002515.1:p.G12X | Transforming Protein N-Ras G12X | NRAS G12X | NRAS p.G12X] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C107483" | eligibility_criterion:"exclusion"} | {"assay_purpose":"Eligibility Criterion - Exclusion" | long_name:"KRAS Exon 3 Gene Mutation" | name:"KRAS Exon 3 Gene Mutation" | synonyms:[] | hugo_biomarker_code:null | nci_thesaurus_concept_id:null | eligibility_criterion:"exclusion"} | {"assay_purpose":"Eligibility Criterion - Exclusion" | long_name:"NRAS Exon 3 Gene Mutation" | name:"NRAS Exon 3 Gene Mutation" | synonyms:[] | hugo_biomarker_code:null | nci_thesaurus_concept_id:null | eligibility_criterion:"exclusion"}]" | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 18 | NCT02196181 | 280 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"BRAF NP_004324.2:p.V600E" | name:"BRAF V600E Mutation" | synonyms:[] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C98342" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"BRAF NP_004324.2:p.V600K Chromosomal mutation" | name:"BRAF V600K Mutation" | synonyms:["BRAF p.Val600Lys" | BRAF NP_004324.2:p.Val600Lys | Serine/Threonine-Protein Kinase B-raf V600K | NP_004324.2:p.Val600Lys | Serine/Threonine-Protein Kinase B-raf Val600Lys | BRAF NP_004324.2:p.V600K | BRAF p.V600K | B-RAF1 c.1798_1799GT>AA] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C98348:C98347" | eligibility_criterion:"inclusion"}]" | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 19 | NCT03244384 | 739 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 20 | NCT02500797 | 195 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 21 | NCT02115282 | 600 | [{assay_purpose":"Eligibility Criterion - Exclusion" | long_name:"HER2/Neu Positive" | name:"HER2/Neu Positive" | synonyms:["HER-2 Positive" | HER2 Positive | ERBB2 Positive] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C68748" | eligibility_criterion:"exclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Progesterone Receptor Positive" | name:"Progesterone Receptor Positive" | synonyms:[" PGR Positive" | PR Positive] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15496" | eligibility_criterion:"inclusion"}]" | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 22 | NCT02224781 | 300 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"BRAF V600 Protein Variation" | name:"BRAF V600 Mutation" | synonyms:["BRAF NP_004324.2:p.V600 Mutation" | BRAF NP_004324.2:p.Val600 Mutation | BRAF p.Val600 Mutation | BRAF p.V600 Mutation | Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation | NP_004324.2:p.Val600 Mutation | NP_004324.2:p.V600 Mutation | Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation | Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C105823" | eligibility_criterion:"inclusion"}]" | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 23 | NCT01872975 | 1636 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 24 | NCT03382561 | 150 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 25 | NCT03033576 | 94 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 26 | NCT02761057 | 180 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 27 | NCT02595424 | 126 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 28 | NCT03468985 | 169 | [{assay_purpose":"Treatment Assignment | Eligibility Criterion - Inclusion" | long_name:"MET Exon 14 Mutation" | name:"MET Exon 14 Mutation" | synonyms:["HGFR Exon 14 Mutation" | Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) Exon 14 Mutation | MET Proto-Oncogene, Receptor Tyrosine Kinase Exon 14 Mutation | c-Met Exon 14 Mutation] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C127129" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Exclusion" | long_name:"ALK Gene Rearrangement Negative" | name:"ALK Gene Rearrangement Negative" | synonyms:["ALK Rearrangement Negative" | Anaplastic Lymphoma Kinase Gene Rearrangement Negative | Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Rearrangement Negative | CD246 Gene Rearrangement Negative] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C134487" | eligibility_criterion:"exclusion"} | {"assay_purpose":"Treatment Assignment | Eligibility Criterion - Inclusion" | long_name:"c-MET Gene Amplification" | name:"MET Gene Amplification" | synonyms:["HGFR Gene Amplification" | c-Met Gene Amplification | Hepatocyte Growth Factor Receptor Gene Amplification | Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) Gene Amplification | MET Proto-Oncogene, Receptor Tyrosine Kinase Gene Amplification] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C43532" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Treatment Assignment | Eligibility Criterion - Inclusion" | long_name:"RET/PTC Rearrangement" | name:"RET Rearrangement" | synonyms:["Ret Proto-Oncogene Rearrangement" | RET-PTC Gene Rearrangement | RET/PTC Gene Rearrangement | RET Gene Rearrangement] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C46005" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Exclusion" | long_name:"EGFR-TKI Sensitizing Mutation" | name:"EGFR Tyrosine Kinase Inhibitor Sensitizing Mutation" | synonyms:["EGFR Mutation Resulting in Tyrosine Kinase Inhibitor Sensitivity" | EGFR-TKI Sensitizing Mutation] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C96861" | eligibility_criterion:"exclusion"} | {"assay_purpose":"Treatment Assignment | Eligibility Criterion - Inclusion" | long_name:"ROS1 Gene Rearrangement" | name:"ROS1 Gene Rearrangement" | synonyms:["ROS Proto-Oncogene 1 | Receptor Tyrosine Kinase Gene Rearrangement" | ROS Gene Rearrangement | c-ros-1 Gene Rearrangement | MCF3 Gene Rearrangement | ROS1 Rearrangement] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C130236" | eligibility_criterion:"inclusion"}]" | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 29 | NCT03092674 | 1670 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 30 | NCT02912559 | 700 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Mismatch Repair Deficiency" | name:"Mismatch Repair Deficiency" | synonyms:["MMR Deficiency" | Mismatch Repair Deficient | dMMR | Deficient DNA Mismatch Repair | Mismatch Repair Deficiency | MMR Deficient] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C136712" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Mismatch Repair Gene Mutation" | name:"MMR Mutation" | synonyms:["Mismatch Repair Gene Mutation" | DNA Mismatch Repair Gene Mutation | MMR Gene Mutation] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C133706" | eligibility_criterion:"inclusion"}]" | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 31 | NCT02601209 | 137 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 32 | NCT03067181 | 1680 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 33 | NCT02734537 | 345 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Human Papillomavirus Negative" | name:"HPV Negative" | synonyms:["Human Papilloma Virus Negative" | Human Papillomavirus Negative] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C131488" | eligibility_criterion:"inclusion"}]" | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 34 | NCT02954874 | 1000 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Estrogen Receptor Negative" | name:"Estrogen Receptor Negative" | synonyms:["ESR Negative" | ER Negative | Negative Estrogen Receptor] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15493" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"HER2/Neu Negative" | name:"HER2/Neu Negative" | synonyms:["HER-2 Negative" | ERBB2 Negative | HER2 Negative] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C68749" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Triple-Negative Breast Cancer Finding" | name:"Triple-Negative Breast Cancer Finding" | synonyms:["Triple-Negative Breast Cancer Result" | Triple Negative Breast Cancer Result | ER/PR/HER2 Negative | ER-negative PR-negative HER2/neu-negative | ESR1/PGR/ERBB2 Negative Finding | ER-Negative PR-Negative ERBB2-Negative | Triple Negative Breast Cancer Finding | ER-PR-HER2/neu-] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C71428" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Progesterone Receptor Negative" | name:"Progesterone Receptor Negative" | synonyms:["PGR Negative" | PR Negative] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15497" | eligibility_criterion:"inclusion"}]" | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 35 | NCT02839707 | 488 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 36 | NCT02032823 | 1500 | [{assay_purpose":"Stratification Factor | Eligibility Criterion - Inclusion" | long_name:"HER2/Neu Negative" | name:"HER2/Neu Negative" | synonyms:["HER-2 Negative" | ERBB2 Negative | HER2 Negative] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C68749" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Stratification Factor | Eligibility Criterion - Inclusion" | long_name:"Progesterone Receptor Negative" | name:"Progesterone Receptor Negative" | synonyms:["PGR Negative" | PR Negative] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15497" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Triple-Negative Breast Cancer Finding" | name:"Triple-Negative Breast Cancer Finding" | synonyms:["Triple-Negative Breast Cancer Result" | Triple Negative Breast Cancer Result | ER/PR/HER2 Negative | ER-negative PR-negative HER2/neu-negative | ESR1/PGR/ERBB2 Negative Finding | ER-Negative PR-Negative ERBB2-Negative | Triple Negative Breast Cancer Finding | ER-PR-HER2/neu-] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C71428" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Response Assessment | Eligibility Criterion - Inclusion" | long_name:"Deleterious BRCA1 Gene Mutation" | name:"Deleterious BRCA1 Gene Mutation" | synonyms:["Deleterious BROVCA1 Gene Mutation" | Deleterious Breast Cancer Type 1 Susceptibility Gene Mutation] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C128814" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Stratification Factor | Eligibility Criterion - Inclusion" | long_name:"Estrogen Receptor Negative" | name:"Estrogen Receptor Negative" | synonyms:["ESR Negative" | ER Negative | Negative Estrogen Receptor] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15493" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Stratification Factor | Eligibility Criterion - Inclusion" | long_name:"Estrogen Receptor Positive" | name:"Estrogen Receptor Positive" | synonyms:["ER Positive" | ESR Positive | Positive Estrogen Receptor] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15492" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Response Assessment | Eligibility Criterion - Inclusion" | long_name:"Deleterious BRCA2 Gene Mutation" | name:"Deleterious BRCA2 Gene Mutation" | synonyms:["Deleterious Breast Cancer Type 2 Susceptibility Gene Mutation" | Deleterious BROVCA2 Gene Mutation] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C128815" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Response Assessment | Eligibility Criterion - Inclusion" | long_name:"BRCA1 Gene Mutation" | name:"BRCA1 Gene Mutation" | synonyms:["Breast Cancer 1 | Early Onset Gene Mutation" | BROVCA1 Gene Mutation | Breast Cancer 1 Gene Mutation | BRCA1 Mutation | Breast Cancer Type 1 Susceptibility Gene Mutation | Mutation of the BRCA1 Gene] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C19635" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Stratification Factor | Eligibility Criterion - Inclusion" | long_name:"Progesterone Receptor Positive" | name:"Progesterone Receptor Positive" | synonyms:[" PGR Positive" | PR Positive] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15496" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Response Assessment | Eligibility Criterion - Inclusion" | long_name:"BRCA2 Gene Mutation" | name:"BRCA2 Gene Mutation" | synonyms:["Breast Cancer Type 2 Susceptibility Gene Mutation" | Mutation of the BRCA2 Gene | BRCA2 Mutation | Breast Cancer 2, Early Onset Gene Mutation | BROVCA2 Gene Mutation | Breast Cancer 2 Gene Mutation] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C19636" | eligibility_criterion:"inclusion"}]" | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 37 | NCT03419234 | 210 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Castration Levels of Testosterone" | name:"Castration Levels of Testosterone" | synonyms:[] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C129259" | eligibility_criterion:"inclusion"}]" | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 38 | NCT01368588 | 2580 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 39 | NCT02893930 | 40 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 40 | NCT01101451 | 360 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 41 | NCT02003222 | 509 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"BCR/ABL1 Fusion Protein Negative" | name:"BCR-ABL1 Fusion Protein Negative" | synonyms:["BCR/ABL1 Fusion Protein Negative" | BCR ABL Fusion Protein Negative | Breakpoint Cluster Region/Tyrosine-Protein Kinase ABL1 Fusion Protein Negative | BCR/ABL Fusion Protein Negative | BCR/ABL Oncoprotein Negative | BCR/ABL1 Protein Negative | BCR-ABL1 Protein Negative | BCR/ABL Chimeric Protein Negative] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C131067" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Philadelphia Chromosome Negative" | name:"Philadelphia Chromosome Negative" | synonyms:["Ph Negative"] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C128844" | eligibility_criterion:"inclusion"}]" | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 42 | NCT02180867 | 340 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 43 | NCT02516423 | 110 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 44 | NCT02567435 | 337 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 45 | NCT03269669 | 150 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 46 | NCT02306161 | 330 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 47 | NCT03191149 | 20 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"EGFR Gene Exon Insertion Mutation Twenty" | name:"EGFR Exon 20 Insertion" | synonyms:["ERBB Exon 20 Insertion Mutation" | ERBB Exon 20 Insertion | Epidermal Growth Factor Receptor Exon 20 Insertion | ERBB1 Exon 20 Insertion Mutation | Epidermal Growth Factor Receptor Exon 20 Insertion Mutation | mENA Exon 20 Insertion Mutation | mENA Exon 20 Insertion | ERBB1 Exon 20 Insertion | PIG61 Exon 20 Insertion | PIG61 Exon 20 Insertion Mutation | EGFR Exon 20 Insertion (ERBB Exon 20 Insertion | HER1 Exon 20 Insertion | HER1 Exon 20 Insertion Mutation | EGFR Exon 20 Insertion Mutation] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C125605" | eligibility_criterion:"inclusion"}]" | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 48 | NCT00492778 | 164 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 49 | NCT03233711 | 200 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 50 | NCT03070886 | 612 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"PSA Level Greater than or Equal to 0.2" | name:"PSA Level 0.2 or Greater" | synonyms:["PSA Level Greater than or Equal to 0.2"] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C138952" | eligibility_criterion:"inclusion"}]" | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 51 | NCT02152137 | 20 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 52 | NCT02997228 | 347 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Mismatch Repair Deficiency" | name:"Mismatch Repair Deficiency" | synonyms:["MMR Deficiency" | Mismatch Repair Deficient | dMMR | Deficient DNA Mismatch Repair | Mismatch Repair Deficiency | MMR Deficient] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C136712" | eligibility_criterion:"inclusion"}]" | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 53 | NCT02883049 | 5956 | [{assay_purpose":"Eligibility Criterion - Exclusion" | long_name:"Mutation Abnormality BCR/ABL1 Fusion Gene" | name:"BCR-ABL fusion mutation" | synonyms:["BCR-ABL Oncogene" | BCR/ABL Oncogene | C45576:C94600 | BCR-ABL | BCR-ABL1 Fusion | BCR/ABL1 fusion mutation | BCR/ABL1 Fusion] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C16325:C94600" | eligibility_criterion:"exclusion"}]" | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 54 | NCT02176967 | 621 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Gain of Chromosome 1q" | name:"1q Amplification" | synonyms:["Gain of Chromosome 1q"] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C36482" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Loss of Chromosome 3p" | name:"Loss of Chromosome 3p" | synonyms:["del(3p)" | 3p Deletion] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C36502" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Loss of Chromosome 11q" | name:"11q Deletion" | synonyms:["del11q" | Loss of Chromosome 11q] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C37312" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Treatment Assignment | Eligibility Criterion - Inclusion" | long_name:"Loss of Heterozygosity" | name:"LOH" | synonyms:["Loss of Heterozygosity"] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C18016" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Loss of Chromosome 1p" | name:"1p Deletion" | synonyms:["del(1p)" | Loss of Chromosome 1p] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C36501" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Gain of Chromosome 2p" | name:"Gain of Chromosome 2p" | synonyms:[] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C36439" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Loss of Chromosome 4p" | name:"Loss of Chromosome 4p" | synonyms:["del(4p)" | 4p Deletion] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C141398" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Exclusion" | long_name:"NMYC Gene Amplification" | name:"MYCN Amplification" | synonyms:["N-myc Gene Amplification" | V-Myc Avian Myelocytomatosis Viral Oncogene Neuroblastoma Derived Homolog Gene Amplification | Neuroblastoma-Derived V-Myc Avian Myelocytomatosis Viral Related Oncogene Amplification | NMYC Gene Amplification] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C36673" | eligibility_criterion:"exclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Gain of Chromosome 17q" | name:"Gain of Chromosome 17q" | synonyms:[] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C36484" | eligibility_criterion:"inclusion"}]" | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 55 | NCT03267433 | 689 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"t(11 | 14)(CLL | IGH) gene translocation" | name:"t(11;14)" | synonyms:["C0808176"] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C128641" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"CCND1 Positive" | name:"CCND1 Positive" | synonyms:["BCL1 Positive" | Cyclin D1 Positive | Cyclin-D1 Positive | BCL-1 Positive | PRAD1 Positive] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C128832" | eligibility_criterion:"inclusion"}]" | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 56 | NCT01096368 | 500 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 57 | NCT03055013 | 766 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 58 | NCT02101853 | 598 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 59 | NCT02521493 | 256 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Blasts 5 Percent or More of Bone Marrow Nucleated Cells" | name:"Blasts 5 Percent or More of Bone Marrow Nucleated Cells" | synonyms:["Blasts Greater than or Equal to 5 Percent of Bone Marrow Nucleated Cells)"] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C136411" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Trisomy 21" | name:"Trisomy 21" | synonyms:[] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C43224" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Trisomy 21 Mosaicism" | name:"Trisomy 21 Mosaicism" | synonyms:[] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C142099" | eligibility_criterion:"inclusion"}]" | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 60 | NCT02339740 | 158 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"PML/RARA Fusion Positive" | name:"PML/RARA Fusion Positive" | synonyms:["PML-RARA Positive" | PML-RAR Alpha Fusion Positive | PML-RAR Alpha Positive | PML-RARA Fusion Positive | PML/RAR Alpha Fusion Positive | PML/RAR Alpha Positive | PML/RARA Positive] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C128836" | eligibility_criterion:"inclusion"}]" | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 61 | NCT02004275 | 97 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 62 | NCT02828358 | 116 | [{assay_purpose":"Treatment Assignment | Eligibility Criterion - Inclusion" | long_name:"MLL Gene Rearrangement" | name:"MLL Gene Rearrangement" | synonyms:["Myeloid/Lymphoid or Mixed-Lineage Leukemia (Trithorax Homolog | Drosophila) Gene Rearrangement" | Lysine (K)-Specific Methyltransferase 2A Gene Rearrangement | KMT2A Gene Rearrangement] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C122623" | eligibility_criterion:"inclusion"}]" | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 63 | NCT02166463 | 600 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 64 | NCT00887146 | 360 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Loss of Chromosomes 1p/19q" | name:"1p/19q Codeletion" | synonyms:["Loss of Chromosomes 1p/19q" | 1p/19q Co-deletion | del(1p/19q)] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C79099" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"IDH1 Gene Mutation" | name:"IDH1 Gene Mutation" | synonyms:["IDH1 Mutation" | Isocitrate Dehydrogenase 1 (NADP+), Soluble Gene Mutation | Isocitrate Dehydrogenase (NADP(+)) 1, Cytosolic Gene Mutation] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C118389" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"IDH2 Gene Mutation" | name:"IDH2 Gene Mutation" | synonyms:["Isocitrate Dehydrogenase 1 (NADP+) | Mitochondrial Gene Mutation" | Isocitrate Dehydrogenase (NADP(+)) 2, Mitochondrial Gene Mutation | IDH2 Mutation] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C118390" | eligibility_criterion:"inclusion"}]" | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 65 | NCT02724579 | 45 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"CTNNB1 Gene Mutation" | name:"CTNNB1 Gene Mutation" | synonyms:["Cadherin-Associated Protein | Beta Gene Mutation" | Catenin Beta 1 Gene Mutation | Beta Catenin Gene Mutation | CTNNB Gene Mutation | Cadherin-Associated Protein, Beta 1 (88kD) Gene Mutation | Catenin Beta-1 Gene Mutation | Beta-Catenin Gene Mutation] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C36659" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"CTNNB1 Positive" | name:"CTNNB1 Positive" | synonyms:["Catenin Beta-1 Positive" | Beta-Catenin Positive | Beta Catenin Positive | CTNNB Positive] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C142133" | eligibility_criterion:"inclusion"}]" | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 66 | NCT03137771 | 186 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 67 | NCT02443077 | 302 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 68 | NCT02179086 | 606 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 69 | NCT02775851 | 77 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 70 | NCT01595061 | 52 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 71 | NCT01979536 | 140 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"TNFRSF8 Positive" | name:"TNFRSF8 Positive" | synonyms:["CD30 Positive" | CD30 Positive: TNFRSF8 Positive | CD30 Antigen Positive | Tumor Necrosis Factor Receptor Superfamily Member 8 Positive] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C129257" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"ALK Positive" | name:"ALK Positive" | synonyms:["Anaplastic Lymphoma Kinase Positive" | ALK-Positive] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C128831" | eligibility_criterion:"inclusion"}]" | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 72 | NCT02135042 | 924 | [{assay_purpose":"Treatment Assignment | Eligibility Criterion - Inclusion" | long_name:"Epstein-Barr Virus DNA Positive" | name:"Epstein-Barr Virus DNA Positive" | synonyms:["HHV4 DNA Positive" | Human Herpesvirus 4 Positive | Human Herpesvirus-4 DNA Positive | EBV DNA Positive | HHV-4 DNA Positive] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C141397" | eligibility_criterion:"inclusion"}]" | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 73 | NCT03007147 | 700 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Philadelphia Chromosome Positive" | name:"Philadelphia Chromosome Positive" | synonyms:["Ph Positive"] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C128843" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"BCR-ABL1 Fusion Protein Expression" | name:"BCR-ABL1 Fusion Protein Positive" | synonyms:["BCR-ABL1 Fusion Protein Expression" | BCR-ABL1 Fusion Protein Positive | BCR/ABL1 Fusion Protein Expression] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C36715" | eligibility_criterion:"inclusion"}]" | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 74 | NCT01220583 | 252 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 75 | NCT02844816 | 148 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 76 | NCT00980954 | 285 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 77 | NCT02364557 | 360 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 78 | NCT03371719 | 324 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"PSA Progression" | name:"PSA Progression" | synonyms:["PSA Elevated" | Elevated Prostate Specific Antigen | Increasing PSA | Elevated PSA | Rising PSA] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C123611" | eligibility_criterion:"inclusion"}]" | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 79 | NCT03367702 | 606 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 80 | NCT03228537 | 28 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 81 | NCT03091660 | 969 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 82 | NCT03150693 | 324 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"CD22 Positive" | name:"CD22 Positive" | synonyms:["Sialic Acid-Binding Immunoglobulin-Like Lectin 2 Positive" | SIGLEC-2 Positive | CD22 Molecule Positive | BL-CAM Positive | B-Cell Receptor CD22 Positive | T-Cell Surface Antigen Leu-14 Positive | SIGLEC2 Positive | B-Lymphocyte Cell Adhesion Molecule Positive | CD22 Antigen Positive | Sialic Acid-Binding Ig-Like Lectin 2 Positive | B-Cell Antigen CD22 Positive] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C131066" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Exclusion" | long_name:"Mutation Abnormality BCR/ABL1 Fusion Gene" | name:"BCR-ABL fusion mutation" | synonyms:["BCR-ABL Oncogene" | BCR/ABL Oncogene | C45576:C94600 | BCR-ABL | BCR-ABL1 Fusion | BCR/ABL1 fusion mutation | BCR/ABL1 Fusion] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C16325:C94600" | eligibility_criterion:"exclusion"} | {"assay_purpose":"Eligibility Criterion - Exclusion" | long_name:"Philadelphia Chromosome" | name:"t(9;22)(q34;q11)" | synonyms:["Philadelphia Translocation" | t(9;22)(q34.1;q11.2) | Philadelphia chromosome | t(9;22)(q34;q11.2) | Philadelphia Chromosome | Ph] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C28452" | eligibility_criterion:"exclusion"}]" | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 83 | NCT02143414 | 44 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 84 | NCT03304639 | 100 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 85 | NCT01042522 | 128 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 86 | NCT03180268 | 148 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 87 | NCT02867592 | 146 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"MITF Positive" | name:"MITF Positive" | synonyms:["Class E Basic Helix-Loop-Helix Protein 32 Positive" | bHLHe32 Positive | Microphthalmia-Associated Transcription Factor Positive | MI Positive] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C146659" | eligibility_criterion:"inclusion"}]" | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 88 | NCT01622868 | 143 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"HER2/Neu Positive" | name:"HER2/Neu Positive" | synonyms:["HER-2 Positive" | HER2 Positive | ERBB2 Positive] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C68748" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"ERBB2 Gene Amplification" | name:"HER2 Amplification" | synonyms:["ERBB2 Gene Amplification" | HER2/Neu Amplification | c-erbB2 Gene Amplification | HER-2 Gene Amplification | ERBB2 Amplification | c-erbB2 Gene Activation | HER2 Gene Amplification] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C36638" | eligibility_criterion:"inclusion"}]" | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 89 | NCT03233204 | 49 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"DNA Damage Response Deficiency Gene Signature" | name:"DDRD Signature" | synonyms:["Deficient DNA Damage Response Gene Signature" | DNA Damage Response Deficiency Gene Signature | DNA Damage Response and Repair Deficiency Gene Signature | DNA Damage Repair Deficiency Gene Signature] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C129891" | eligibility_criterion:"inclusion"}]" | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 90 | NCT03220035 | 49 | [{assay_purpose":"Treatment Assignment | Eligibility Criterion - Inclusion" | long_name:"BRAF V600 Protein Variation" | name:"BRAF V600 Mutation" | synonyms:["BRAF NP_004324.2:p.V600 Mutation" | BRAF NP_004324.2:p.Val600 Mutation | BRAF p.Val600 Mutation | BRAF p.V600 Mutation | Serine/Threonine-Protein Kinase B-raf Protein V600 Mutation | NP_004324.2:p.Val600 Mutation | NP_004324.2:p.V600 Mutation | Serine/Threonine-Protein Kinase B-raf Protein Val600 Mutation | Serine/Threonine-Protein Kinase B-raf Protein V600 Protein Variation] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C105823" | eligibility_criterion:"inclusion"}]" | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 91 | NCT03210714 | 49 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 92 | NCT03213652 | 98 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"ALK Gene Alteration Positive" | name:"ALK Gene Alteration Positive" | synonyms:["CD246 Gene Alteration Positive" | Anaplastic Lymphoma Kinase Gene Alteration Positive | Anaplastic Lymphoma Receptor Tyrosine Kinase Gene Alteration Positive] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C134458" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"ROS1 Gene Alteration Positive" | name:"ROS1 Gene Alteration Positive" | synonyms:["ROS Gene Alteration Positive" | ROS Proto-Oncogene 1, Receptor Tyrosine Kinase Gene Alteration Positive | c-ros-1 Gene Alteration Positive | MCF3 Gene Alteration Positive] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C134454" | eligibility_criterion:"inclusion"}]" | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 93 | NCT02375204 | 420 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Elevated Human Chorionic Gonadotropin" | name:"Elevated HCG" | synonyms:["Elevated Human Chorionic Gonadotropin"] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C136631" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Elevated Alpha-Fetoprotein" | name:"Elevated AFP" | synonyms:["Elevated Alpha-Fetoprotein"] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C136630" | eligibility_criterion:"inclusion"}]" | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 94 | NCT03213704 | 49 | [{assay_purpose":"Treatment Assignment | Eligibility Criterion - Inclusion" | long_name:"NTRK2 Fusion Positive" | name:"NTRK2 Fusion Positive" | synonyms:["NTRK2 Fusion" | BDNF/NT-3 Growth Factors Receptor Fusion Positive | TRKB Tyrosine Kinase Fusion Positive | TrkB Fusion Positive | Tropomyosin-Related Kinase B Fusion Positive] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C132235" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Treatment Assignment | Eligibility Criterion - Inclusion" | long_name:"NTRK3 Fusion Positive" | name:"NTRK3 Fusion Positive" | synonyms:["TRKC Tyrosine Kinase Fusion Positive" | TrkC Fusion Positive | Neurotrophic Tyrosine Kinase Receptor Type 3 Fusion Positive | NTRK3 Fusion | NT-3 Growth Factor Receptor Fusion Positive] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C132236" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Treatment Assignment | Eligibility Criterion - Inclusion" | long_name:"NTRK1 Fusion Positive" | name:"NTRK1 Fusion" | synonyms:["NTRK1 Fusion Positive" | TRKA Fusion Positive | High Affinity Nerve Growth Factor Receptor Fusion Positive | Tropomyosin-Related Kinase A Fusion Positive | Neurotrophic Receptor Tyrosine Kinase 1 Fusion Positive | Trk-A Fusion Positive | TRK1 Fusion Positive] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C131070" | eligibility_criterion:"inclusion"}]" | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 95 | NCT03224767 | 36 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"BRAF NP_004324.2:p.V600E" | name:"BRAF V600E Mutation" | synonyms:[] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C98342" | eligibility_criterion:"inclusion"}]" | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 96 | NCT03375320 | 395 | null | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 97 | NCT03213678 | 144 | [{assay_purpose":"Treatment Assignment | Eligibility Criterion - Inclusion" | long_name:"TSC1 Gene Mutation" | name:"TSC1 Gene Mutation" | synonyms:["TSC1 Mutation" | Tuberous Sclerosis 1 Gene Mutation | TSC Gene Mutation] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C118398" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Treatment Assignment | Eligibility Criterion - Inclusion" | long_name:"TSC2 Gene Mutation" | name:"TSC2 Gene Mutation" | synonyms:["Tuberous Sclerosis 2 Gene Mutation" | TSC2 Mutation] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C118399" | eligibility_criterion:"inclusion"}]" | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 98 | NCT03533582 | 1220 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"SMARCB1 Positive" | name:"SMARCB1 Positive" | synonyms:[] | hugo_biomarker_code:null | nci_thesaurus_concept_id:null | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Elevated Alpha-Fetoprotein" | name:"Elevated AFP" | synonyms:["Elevated Alpha-Fetoprotein"] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C136630" | eligibility_criterion:"inclusion"}]" | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 99 | NCT02513394 | 5600 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"HER2/Neu Negative" | name:"HER2/Neu Negative" | synonyms:["HER-2 Negative" | ERBB2 Negative | HER2 Negative] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C68749" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Estrogen Receptor Positive" | name:"Estrogen Receptor Positive" | synonyms:["ER Positive" | ESR Positive | Positive Estrogen Receptor] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15492" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Progesterone Receptor Positive" | name:"Progesterone Receptor Positive" | synonyms:[" PGR Positive" | PR Positive] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15496" | eligibility_criterion:"inclusion"}]" | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 100 | NCT02849496 | 72 | [{assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"BRCA1 Gene Mutation" | name:"BRCA1 Gene Mutation" | synonyms:["Breast Cancer 1 | Early Onset Gene Mutation" | BROVCA1 Gene Mutation | Breast Cancer 1 Gene Mutation | BRCA1 Mutation | Breast Cancer Type 1 Susceptibility Gene Mutation | Mutation of the BRCA1 Gene] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C19635" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"BRCA2 Gene Mutation" | name:"BRCA2 Gene Mutation" | synonyms:["Breast Cancer Type 2 Susceptibility Gene Mutation" | Mutation of the BRCA2 Gene | BRCA2 Mutation | Breast Cancer 2, Early Onset Gene Mutation | BROVCA2 Gene Mutation | Breast Cancer 2 Gene Mutation] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C19636" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"HER2/Neu Negative" | name:"HER2/Neu Negative" | synonyms:["HER-2 Negative" | ERBB2 Negative | HER2 Negative] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C68749" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Progesterone Receptor Negative" | name:"Progesterone Receptor Negative" | synonyms:["PGR Negative" | PR Negative] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15497" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Triple-Negative Breast Cancer Finding" | name:"Triple-Negative Breast Cancer Finding" | synonyms:["Triple-Negative Breast Cancer Result" | Triple Negative Breast Cancer Result | ER/PR/HER2 Negative | ER-negative PR-negative HER2/neu-negative | ESR1/PGR/ERBB2 Negative Finding | ER-Negative PR-Negative ERBB2-Negative | Triple Negative Breast Cancer Finding | ER-PR-HER2/neu-] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C71428" | eligibility_criterion:"inclusion"} | {"assay_purpose":"Eligibility Criterion - Inclusion" | long_name:"Estrogen Receptor Negative" | name:"Estrogen Receptor Negative" | synonyms:["ESR Negative" | ER Negative | Negative Estrogen Receptor] | hugo_biomarker_code:null | nci_thesaurus_concept_id:"C15493" | eligibility_criterion:"inclusion"}]" |